MedTrace Logo

Lenstec Tetraflex Accommodating Posterior Chamber Intraocular Lens (IOL) Clinical Investigation

NCT00969371 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 470

Last updated 2018-10-18

No results posted yet for this study

Summary

The purpose of the following clinical protocol is to evaluate the safety and effectiveness of the Lenstec Tetraflex Accommodating Posterior Chamber Intraocular Lens (IOL) for the protocol inclusion/exclusion criteria.

Conditions

  • Cataract

Interventions

DEVICE

posterior chamber IOL implantation

DEVICE

Experimental TetraFlex Study IOL

TetraFlex IOL implanted

Sponsors & Collaborators

  • Lenstec Incorporated

    lead INDUSTRY

Principal Investigators

  • Donald R Sanders, MD, PhD · Center for Clinical Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2009-06-30
Completion
2009-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00969371 on ClinicalTrials.gov